Adma Biologics reported $266.12M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Adma Biologics USD 266.12M 26.8M Sep/2026
Alnylam Pharmaceuticals USD 105.91M 8.8M Sep/2026
BioCryst Pharmaceuticals USD 13.74M 7.68M Sep/2026
Novavax USD 18.5M 8.49M Sep/2026
Omeros USD 712K 266K Sep/2021
Takeda JPY 1.44T 6.17B Sep/2026